Tongji Xie

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Top Venues

NPJ precision oncology

Molecular cancer research : MCR

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Guangyu Fan, Tongji Xie, Lin Li, Le Tang, Xiaohong Han, Yuan-Kai Shi
Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma. NPJ precision oncology 8 (1) (2024)
Guangyu Fan, Tongji Xie, Lin Li, Le Tang, Xiaohong Han, Yuan-Kai Shi
Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma. NPJ precision oncology 8 (1) (2024)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics 14 (22) (2023)
Tongji Xie, Guangyu Fan, Liling Huang, Ning Lou, Xiao-Hong Han, Pu-Yuan Xing, Yuan-Kai Shi
Analysis on methylation and expression of PSMB8 and its correlation with immunity and immunotherapy in lung adenocarcinoma. Epigenomics (2023)
Liling Huang, Tongji Xie, Fuqiang Zhao, Yu Feng, Hao-Hua Zhu, Le Tang, Xiao-Hong Han, Yuan-Kai Shi
DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis. Disease markers 2022 (2022)
Tongji Xie, Zhenghao Liu, Yan Li, Shou-Zheng Wang, Yixin Zhai, Fei Teng, Xuezhi Hao, Yan Wang, Hongyu Wang, Xin Zhang, Xi Wu, Jianming Ying, Jun-Ling Li, Ye Zhang, Yuefei Deng, Pu-Yuan Xing
Evolutionary characteristics and immunological divergence of lung and brain metastasis lesions in NSCLC. Molecular cancer research : MCR (2022)
Tongji Xie, Zihua Zou, Chengcheng Liu, Yi-Xiang Zhu, Ziyi Xu, Le Wang, Jun-Ling Li, Pu-Yuan Xing
Front-Line Therapy in EGFR Exon 19 Deletion and 21 Leu858Arg Mutations in Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)